Bessemer Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11K | Hold |
3,513
| – | – | ﹤0.01% | 1798 |
|
2025
Q1 | $12K | Hold |
3,513
| – | – | ﹤0.01% | 1718 |
|
2024
Q4 | $20K | Hold |
3,513
| – | – | ﹤0.01% | 1529 |
|
2024
Q3 | $21K | Hold |
3,513
| – | – | ﹤0.01% | 1491 |
|
2024
Q2 | $28K | Hold |
3,513
| – | – | ﹤0.01% | 1349 |
|
2024
Q1 | $33K | Hold |
3,513
| – | – | ﹤0.01% | 1370 |
|
2023
Q4 | $30K | Hold |
3,513
| – | – | ﹤0.01% | 1412 |
|
2023
Q3 | $27K | Hold |
3,513
| – | – | ﹤0.01% | 1427 |
|
2023
Q2 | $40K | Sell |
3,513
-35,474
| -91% | -$404K | ﹤0.01% | 1411 |
|
2023
Q1 | $301K | Buy |
+38,987
| New | +$301K | ﹤0.01% | 827 |
|
2018
Q4 | – | Sell |
-43,636
| Closed | -$826K | – | 2069 |
|
2018
Q3 | $826K | Buy |
+43,636
| New | +$826K | ﹤0.01% | 622 |
|
2017
Q3 | – | Sell |
-44,828
| Closed | -$402K | – | 1897 |
|
2017
Q2 | $402K | Buy |
44,828
+26,763
| +148% | +$240K | ﹤0.01% | 906 |
|
2017
Q1 | $239K | Sell |
18,065
-3,753
| -17% | -$49.7K | ﹤0.01% | 1050 |
|
2016
Q4 | $278K | Buy |
+21,818
| New | +$278K | ﹤0.01% | 1019 |
|